Deep vein thrombosis (DVT) is a blood clot that develops within a deep vein, usually in the leg. It can cause pain, swelling, tenderness and red skin but sometimes there are no symptoms. Risk factors ...
GALWAY, Ireland--(BUSINESS WIRE)--Vetex Medical Ltd. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the ReVene® Thrombectomy Catheter. ReVene uses dual-action technology ...
Just as catheter angiography in the assessment of peripheral vascular disease has largely been replaced by CT or MRI angiography, so too catheter venography has been replaced by ultrasound and or CT ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...
Current evidence on the safety of percutaneous mechanical thrombectomy for acute deep vein thrombosis (DVT) of the leg shows there are well-recognised but infrequent complications. For acute ...
In essence, patients with IF DVT who receive warfarin must have it overlapped with initial AC (usually heparin or LMWH) until INR >2 for at least 24 h with a target INR of 2–3. If the IF DVT was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results